Hormonal treatment of male infertility: Promise and pitfalls

Journal of Andrology

Volumn 30, Issue 2, 2009, Pages 95-112

  Madhukar, Dama ^a   Rajender, Singh ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

In vitro fertilization; Oligozoospermia; Spermatogenesis

Indexed keywords

AMITRIPTYLINE; ANDROGEN; ANDROSTANOLONE; ANTIESTROGEN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; CORTICOSTEROID DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; EPHEDRINE; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADORELIN DERIVATIVE; GONADOTROPIN DERIVATIVE; GROWTH HORMONE; HUMAN MENOPAUSAL GONADOTROPIN; KALLIKREIN; LUTEINIZING HORMONE; MESTEROLONE; PLACEBO; RECOMBINANT FOLLITROPIN; RECOMBINANT GROWTH HORMONE; TAMOXIFEN CITRATE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; UNINDEXED DRUG;

ASTHENOSPERMIA; CLINICAL TRIAL; DRUG MEGADOSE; DRUG RECEPTOR BINDING; FERTILIZATION IN VITRO; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTRACYTOPLASMIC SPERM INJECTION; LOW DRUG DOSE; MALE INFERTILITY; MALE STERILIZATION REVERSAL; NONHUMAN; OLIGOSPERMIA; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SPERM RETRIEVAL; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY;

HORMONES; HUMANS; INFERTILITY, MALE; MALE;

EID: 62649107949     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.108.005694     Document Type: Review

References (192)

1. Aafjes JH, van der Vijver JC, Brugman FW, Schenck PE. Double-blind cross over treatment with mesterolone and placebo of subfertile oligozoospermic men value of testicular biopsy. Andrologia. 1983;15:531-535.
2. Abalovich M, Levalle O, Hermes R, Scaglia H, Aranda C, Zylbersztein C, Oneto A, Aquilano D, Gutierrez S. Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males. Thyroid. 1999;9:857-863.
3. Abel BJ, Carswell G, Elton R, Hargreave TB, Kyle K, Orr S, Rogers A, Baxby K, Yates A. Randomised trial of clomiphene citrate treatment and vitamin C for male infertility. Br J Urol. 1982;54: 780-784.
4. Adamopoulos DA. Medical treatment of idiopathic oligozoospermia and male factor subfertility. Asian J Androl. 2000;2:25-32.
5. Adamopoulos DA, Nicopoulou S, Kapolla N, Karamertzanis M, Andreou E. The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia. Fertil Steril. 1997;67:756-762.
6. Adamopoulos DA, Pappa A, Billa E, Nicopoulou S, Koukkou E, Michopoulos J. Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia. Fertil Steril. 2003;80:914-920.
7. Adeoya-Osiguwa SA, Markoulaki S, Pocock SV, Milligan SR, Fraser LR. 17beta-Estradiol and environmental estrogens significantly affect mammalian sperm function. Hum Reprod. 2003;18:100-107.
8. AinMelk Y, Belisle S, Carmel M, Jean-Pierre T. Tamoxifen citrate therapy in male infertility. Feral Steril. 1987;48:113-117.
9. Anderson RA, Van Der Spuy ZM, Dada OA, Tregoning SK, Zinn PM, Adeniji OA, Fakoya TA, Smith KB, Baird DT. Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone. Hum Reprod. 2002; 17:2869-2877.
10. Aravidan GR, Gopalakrishnan K, Ravindranath N, Moudgal NR. Effect of altering endogenous gonadotrophin concentrations on the kinetics of testicular germ cell turnover in the bonnet monkey (Macaca radiala). J Endocrinol. 1993;137:485-495.
11. Ashkenazi J, Bar-Hava I, Farhi J, Levy T, Feldberg D, Orvieto R, Ben-Rafael Z. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril. 1999;72:670-673.
12. Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med. 1995;332(5):281-285.
13. Aulitzky W, Frick J, Hadziselimovic F. Pulsatile LHRH therapy in patients with oligozoospermia and disturbed LH pulsatility. Int J Androl. 1989;12:265-272.
14. Baccetti B, Piomboni P, Bruni E, Capitani S, Gambera L, Moretti E, Sterzik K, Strehler E. Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. Asian J Androl. 2004;6:133-137.
15. Baccetti B, Strehler E, Capitani S, Collodel G, De Santo M, Moretti E, Piomboni P, Wiedeman R, Sterzik K. The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae 11). Hum Reprod. 1997;12:1955-1968.
16. Badenoch DF, Waxman J, Boorman L, Sidhu B, Moore HD, Holt WV, Blandy JP. Administration of a gonadotropin releasing hormone analogue in oligozoospermic infertile males. Acta Endocrinol. 1988; 117:265-267.
17. Bakircioglu ME, Erden HF, Ciray HN, Bayazit N, Bahçeci M. Gonadotrophin therapy in combination with ICSI in nien with hypogonadotrophic hypogonadism. Reprod Biomed Online. 2007; 15:156-160.
18. Bartsch G, Scheiber K. Tamoxifen treatment in oligozoospermia. Eur Urol. 1981;7:283-287.
19. Beamer WG, Eicher EM, Maltais U, Southard JL. Inherited primary hypothyroidism in mice. Science. 1981;212:61-63.
20. Ben-Rafael, Farhi J, Feldberg D, Bartoov B, Kovo M, Eltes F, Ashkenazi J. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril. 2000;73:24-30.
21. Beretta G, Fino E, Sibilio L, Dilena M. Menotropin (hMG) and idiopathic oligoasthenoteratozoospermia (OAT): effects on seminal fluid parameters and on results in ICSI cycles. Arch Ital Urol Androl. 2005;77:18-21.
22. Bhasin S, de Kretser DM, Baker HW. Clinical review 64: pathophysiology and natural history of male infertility. J Clin Endocrinol Metab. 1994;79(6):1525-1529.
23. Blumenfeld Z, Makler A, Frisch L, Brandes JM. Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH). Gynecol Endocrinol. 1988;2:151-164.
24. Breier BH, Vickers MH, Gravance CG, Casey PJ. Therapy with growth hormone: major prospects for the treatment of male subfertility? Endocr J. 1998;45(suppl S):53-60.
25. Brennemann W, Brensing KA, Leipner N, Boldt I, Klingmuller D. Attempted protection of spermatogenesis from irradiation in patients with seminoma by D-tryptophan-6 luteinizing hormone releasing hormone. Clin Investig. 1994;72:838-842.
26. Breznik R, Borko E. Effectiveness of antiestrogens in infertile men. Arch Androl. 1993;31:43-48.
27. Brigante C, Motta G, Fusi F, Coletta MP, Busacca M. Treatment or idiopathic oligozoospermia with tamoxifen. Acta Eur Fertil. 1985; 16:361-364.
28. Buchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotrophin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139: 298-303.
29. Burger HG, Baker HWG. Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism. Ann N Y Acad Sci. 1984;438:447-453.
30. Burgués S, Calderón MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum Reprod. 1997;12:980-986.
31. Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab. 1988;66:1144-1151.
32. Buvat J, Ardaens K, Lemaire A, Gauthier A, Gasnault JP, Buvat-Herbaut M. Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen. Fertil Steril. 1983;39:700-703.
33. Caroppo E, Niederberger C, Iacovazzi PA, Correale M, Palagiano A, D'Amat G. Human chorionic gonadotropin free beta-subunit in the human seminal plasma: a new marker for spermatogenesis? Eur J Obstet Gynecol Reprod Biol. 2003a;106:165-169.
34. Caroppo E, Niederberger C, Vizziello GM, D'Amato G. Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. Fertil Steril. 2003b;80:1398-1403.
35. Carrell DT, Peterson CM, Urry RL. The binding of recombinant human relaxin to human spermatozoa. Endocr Res. 1995;21:697-707.
36. Charny CW. Clomiphene therapy in male infertility: a negative report. Fertil Steril. 1979;32:551-555.
37. Charny CW, Gordon JA. Testosterone rebound therapy: a neglected modality. Fertil Steril. 1978;29:64-68.
38. Chehval MJ, Mehan DJ. Chorionic gonadotropins in the treatment of the subfertile male. Fertil Steril. 1979;31:666-668.
39. Chowdury AR, Arora U. Role of thyroid in testicular development of immature rat. Arch Androl. 1984;12:49-51.
40. Chowdury AR, Gautam AK, Chatterjee BB. Thyroid-testis interrelationship during the development and sexual maturity of the rat. Arch Androl. 1984;13:233-239.
41. Chubb C, Henry L. The fertility of hypothyroid male mice. J Reprod Fertil. 1988;83:819-823.
42. Chubb C, Nolan C. Animal models of male infertility: mice bearing. single-gene mutations that induce infertility. Endocrinology. 1985; 117:338-346.
43. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougnères P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398-401.
44. Champion ZJ, Vickers MH, Gravance CG, Breier BH, Casey PJ. Growth hormone or insulin-like growth factor-I extends longevity of equine spermatozoa in vitro. Theriogenology. 2002;57:1793-1800.
45. Cochius JI, Hyman N, Esiri MM, Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case. J Neurol Neurosurg Psychiatry. 1992;55:1094-1095.
46. Colon JM, Ginsburg F, Lessing JB, Schoenfeld C, Goldsmith LT, Amelar RD, Dubin L, Weiss G. The effect of relaxin and prostaglandin E2 on the motility of human spermatozoa. Fertil Steril. 1986;46:1133-1139.
47. Comhaire F. Treatment of idiopathic testicular failure with high-dose testosterone undecanoate: a double-blind pilot study. Fertil Steril. 1990;54:689-693.
48. Comhaire F, Schoonjans F, Abdelmassih R, Gordts S, Campo R, Dhont M, Milingos S, Gerris J. Does treatment with testosterone undecanoate improve the in-vitro fertilizing capacity of spermatozoa in patients with idiopathic testicular failure? (results of a double blind study). Hum Reprod. 1995;10:2600-2602.
49. Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annu Rev Med. 1994;45:391-405.
50. Cooke PS, Hess RA, Porcelli J, Meisami E. Increased sperm production in adult rats following transient neonatal hypothyroidism. Endocrinology. 1991;129:244-248.
51. Corrales-Hernandez JJ, Miralles-Garcia JM, Garcia-Diez LC. Primary hypothyroidisin and human spermatogenesis. Arch Androl. 1990; 25:21-27.
52. Crowley WF Jr, Filicori M, Spratt DI, Santoro NF. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res. 1985;41:473-531.
53. Damber JE, Abramsson L, Duchek M. Tamoxifen treatment of idiopathic oligozoospermia: effect on hCG-induced testicular steroidogenesis and semen variables. Scand J Urol Nephrol. 1989;23:241-246.
54. Danner C, Frick J, Maier F. Results of treatment with tamoxifen in oligozoospermic men. Andrologia. 1983;15:584-587.
55. Delemarre-Van de Waal HA. Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism. Clin Endocrinol. 1993;38:473-480.
56. Dirnfeld M, Katz G, Calderon I, Abramovici H, Bider D. Pure follicle-stimulating hormone as an adjuvant therapy for selected cases in male infertility during in-vitro fertilization is beneficial. Eur J Obstet Gynecol Reprod Biol. 2000;93:105-108.
57. Dohle GR, Smit M, Weber RF. Androgens and male fertility. World J Urol. 2003;21:341-345.
58. D'Souza UJ. Effect of tamoxifen on spermatogenesis and tubular morphology in rats. Asian J Androl. 2004;6:223-226.
59. Emons G, Muller V, Ortmann O, Schulz KD. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. J Steroid Biochem Mol Biol. 1998;65:199-206.
60. Epstein JA. Clomiphene treatment in oligospermic infertile males. Fertil Steril. 1977;28:741-745.
61. Essig M, Schoenfeld C, Amelar RD, Dubin L, Weiss G. Stimulation of human sperm motility by relaxin. Fertil Steril. 1982;38:339-343.
62. European Metrodin HP Study Group. Efficacy and safety of highly purified urinary follicle stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertil Steril. 1998;70:256-262.
63. Fauser BC, Rolland R, Dony JM, Corbey RS. Long-term, pulsatile, low dose, subcutaneous luteinizing hormone-releasing hormone administration in men with idiopathic oligozoospermia. Failure of therapeutic and hormonal response. Andrologia. 1985;17:143-149.
64. Fink G. Gonadotropin secretion and its control. In: Knobil E, Neill JD, eds. The Physiology of Reproduction. New York, NY: Raven Press; 1988:1349-1377.
65. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med. 1985;12:651-655.
66. Finkelstein JS, O'Dea LSL, Whitcomb RW, Crowley WF. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administered in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 1991;70:621-628.
67. Foresta C, Bettella A, Garolla A, Ambrosini G, Ferlin A. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril. 2005;84:654-661.
68. Foresta C, Bettella A, Merico M, Garolla A, Ferlin A, Rossato M. Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril. 2002;77:238-244.
69. Foss GL, Tindall VR, Birkett JP. The treatment of subfertile men with clomiphene citrate. J Reprod Fertil. 1973;32:167-170.
70. Furr BJA, Jordan VC. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther. 1984;25:127-205.
71. Gerris J, Comhaire F, Hellemans P, Peeters K, Schoonjans F. Placebo-controlled trial of high-dose Mesterolone treatment of idiopathic male infertility. Fertil Steril. 1991;55:603-607.
72. Giltay JC, Deege M, Blankenstein RA, Kastrop PM, Wijmenga C, Lock TT. Apparent primary follicle-stimulating hormone deficiency is it rare cause of treatable male infertility. Fertil Steril. 2004;81:693-696.
73. Gnessi L, Fabbri A, Spera G. Gonadal peptides as mediators of development and functional control of the testis: an integrated system with hormones and local environment. Endocr Rev. 1997;18:541-609.
74. Gooren L. Improvement of spermatogenesis after treatment with the antiestrogen tamoxifen in a man with the incomplete androgen insensitivity syndrome. J Clin Endocrinol Metab. 1989; 68:1207-1210.
75. Gravance CG, Breier BH, Vickers MH, Casey PJ. Impaired sperm charactcristics in postpubertal growth-hormone-deficient dwarf (dw/dw) rats. Anim Reprod Sci. 1997;49:71-76.
76. Gregoriou O, Papadias C, Gargaropoulos A, Konidaris S, Kontogeorgi Z, Kalampokas E. Treatment of idiopathic infertility with testosterone undecanoate. A double blind study. Clin Exp Obstet Gynecol. 1993;20:9-12.
77. Griboff SI. Semen analysis in myxedema. Fertil Steril. 1962;13:436-443.
78. Guzick DS, Overstreet JW, Factor-Litvak P. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med. 2001;345:1388-1393.
79. Hampl R, Heresová J, Lachman M, Sulcová J, Stárka L. Hormonal changes in tamoxifen treated men with idiopathic oligozoospermia. Exp Clin Endocrinol. 1988;92:211-216.
80. Han YJ, Miah AG0, Yoshida M, Sasada H, Hamano K, Kohsaka T, Tsujii H. Effect of relaxin on in vitro fertilization of porcine oocytes. J Reprod Dev. 2006;52:657-662.
81. Handelsman DJ, Jansen RPS, Boylan LM. Spaliviero JA, Turtle JR. Pharmacokinetics of gonadotropin-releasing hormone: comparison of subcutaneous and intravenous routes. J Clin Endocrinol Metab. 1984;59:739-746.
82. Hargreave TB, Kyle KF, Baxby K, Rogers AC, Scott R, Tolley DA, Abel BJ, Orr PS, Elton RA. Randomised trial of mesterolone versus vitamin C for male infertility. Scottish Infertility Group. Br J Urol. 1984;56:740-744.
83. Harris MA, Rees JM, McLaughlin EA, Ford WC, Wardle PG, Hull MG, Wathes DC. An evaluation of the role of relaxin in the penetration of cervical mucus by spermatozoa. Hum Reprod. 1988;3:856-860.
84. Hayashi N, Sugimura Y, Hori N, Yamamoto I, Tazima K, Tochigi H, Kawamura J. Clomiphene citrate therapy in idiopathic male infertility. Hinyokika Kiyo. 1988;34:847-850.
85. Hess RA, Bunick D, Lee KH, Bahr J, Tavlor JA, Korach KS, Lubahn DB. A role for oestrogens in the male reproductive system. Nature. 1997;390:509-512.
86. Höbarth K, Lunglmayr G, Kratzik C. Effect of tamoxifen and kallikrein on sperm parameters including hypoosmotic swelling test in subfertile males. A retrospective analysis. Andrologia. 1990;22: 513-517.
87. Hoffmann B, Schuler G. Receptor blockers - general aspects with respect to their use in domestic animal reproduction. Anim Reprod Sci. 2000;60-61:295-312.
88. Homonnai ZT, Peled M, Paz GF. Changes in semen quality and fertility in response to endocrine treatment of subfertile men. Gynecol Obstet Invest. 1978;9:244-255.
89. Homonnai ZT, Yavetz H, Yogev L, Rotem R, Paz GF. Clomiphene citrate treatment in oligozoospermia: comparison between two regimens of low-dose treatment. Fertil Steril. 1988;50:801-804.
90. Hull KL, Harvey S. Growth hormone: a reproductive endocrine-paracrine regulator? Rev Reprod. 2000a;5:175-182.
91. Hull KL, Harvey S. Growth hormone: roles in male reproduction. Endocrine. 2000b;3:243-250.
92. Jarow JP. Endocrine causes of male infertility. Urol Clin North Am. 2003;30:83-90.
93. Jaya Kumar B, Khurana ML, Ammini AC. Reproductive endocrine functions in men with primary hypothyroidism: effect of thyroxine replacement. Horm Res. 1990;34:215-218.
94. Johnson DH, Linde R, Hainsworth JD, Vale W, Rivier J, Stein R, Flexner J, Van Welch R, Greco FA. Effect of luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations. Blood. 1985;65:832-836.
95. Jones TH, Darne JF. Self-administered subcutuneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotropic hypogonadism. Clin Endocrinol. 1993;38:203-208.
96. Jungck EC, Roy S, Greenblatt RB, Mahesh VB. Effect of clomiphene citrate on spermatogenesis in the human. A preliminary report. Fertil Steril. 1964;15:40-43.
97. Kadioglu TC, Köksal IT, Tunç M, Nane I, Tellaloglu S. Treatment of idiopathic and postvaricocelectomy oligozoospermia with oral tamoxifen citrate. BJU Int. 1999;83:646-648.
98. Kamischke A, Behre HM, Bergmann M, Simoni M, Schafer T, Nieschlag E. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod. 1998;13: 596-603.
99. Kamischke A, Nieschlag E. Analysis of medical treatment of male infertility. Hum Reprod. 1999;14:1-23.
100. 1 rat. Biol Reprod. 1996;54:1200-1208.
101. Kiesel LA, Rody A, Greb RR, Szilagyi A. Clinical use of GnRH analogues. Clin Endocrinol (Oxf). 2002;56:677-687.
102. Kliesch S, Behre HM, Nieschlag E. High efficacy of gonadotrophin or pulsatile gonadotrophin-releasing hormone treatment in hypogonadotrophic hypogonadal men. Eur J Endocrinol. 1994;131:347-354.
103. Klingmuller D, Schweikert HU. Maintenance of spermatogenesis by intranasal administration of gonadotropin-releasing hormone in patients with hypothalamic hypogonadism. J Clin Endocrinol Metab. 1985;61:868-872.
104. Knuth UA, Hönigl W, Bals-Pratsch M, Schleicher G, Nieschlag E. Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-conlrolled, double blind trial. J Clin Endocrinol Metab. 1987;65:1081-1087.
105. Kotoulas IG, Cardamakis E, Michopoulas J, Mitropoulos D, Dounis A. Tamoxifen treatment in male infertility. I. Effect on spermatozoa. Fertil Steril. 1994;61:911-914.
106. Krause W, Holland-Moritz H, Schramm P. Treatment of idiopathic oligozoospermia with tamoxifen - a randomized controlled study. Int J Androl. 1992;15:14-18.
107. A administration during adjuvant chemotherapy in patients with germ cell tumors. Horm Metab Res. 1990;22:494-498.
108. Kung AW, Zhong YY, Lam KS, Wang C. Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism. Int J Androl. 1994;17:241-247.
109. Lamensdorf H, Compere D, Begley G. Testosterone rebound therapy in the treatment of male infertility. Fertil Steril. 1975;26:469-472.
110. Laron Z, Klinger B. Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance). Eur J Endocrinol. 1998;138:176-180.
111. Lauber ME, Sarasin A, Lichtensteiger W. Sex differences and androgen-dependent regulation of aromatase (CYP19) mRNA expression in the developing and adult rat brain. J Steroid Biochem Mol Biol. 1997;61:359-364.
112. Lee KO, Ng SC, Lee PS, Bongso AT, Taylor EA, Lin TK, Ratnam SS. Effect of growth hormone therapy in men with severe idiopathic oligozoospermia. Eur J Endocrinol. 1995;132:159-162.
113. Lewis-Jones DI, Lynch RV, Machin DC, Desmond AD. Improvement in semen quality in infertile males after treatment with tamoxifen. Andrologia. 1987;19:86-90.
114. Ley SB, Leonard JM. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab. 1985;61:746-752.
115. Lindner J, McNeil LW, Marney S, Conway M, Rivier J, Vale W, Rabin D. Characterization of human anti-luteinizing hormone releasing hormone (LRH) antibodies in the serum of a patient with isolated gonadotropin deficiency treated with synthetic LRH. J Clin Endocrinol Metab. 1981;52:267-270.
116. Liu L, Banks SM, Banres KM, Sherins RJ. Two year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1988;67:1140-1145.
117. Liu PY, Gabski VJ, Turner L, Conway AJ, Wishart SM, Handelsman DJ. Predicting pregnancy and spermatogenesis by survival analysis during gonadotropin treatment of gonadotropin deficient infertile men. Hum Reprod. 2002;17:625-633.
118. Liu PY, Handelsman DJ. The present and future state of hormonal treatment for male infertility. Hum Reprod Update. 2003; 9:9-23.
119. Lowe JE, Baldwin BH, Foote RH, Hillman RB, Kallfelz FA. Semen characteristics in thyroidectomized stallions. J Reprod Fertil Suppl. 1975;23:81-86.
120. Lukola A, Sundqvist C. Improved sperm counts in mink males (Mustela vison) treated with clomiphene citrate. J Endocrinol Invest. 1986;9:243-244.
121. Lyon MF, Glenister PH, Lamoreaux ML. Normal spermatozoa from androgen-resistant germ cells of chimaeric mice and the role of androgen in spermatogenesis. Nature. 1975;258:620-622.
122. Maier U. Systemic therapy of male subfertility. Wien Klin Wochenschr. 1989;101:673-679.
123. Maier U, Hienert G. Tamoxifen and kallikrein in therapy of oligoasthenozoospermia: results of a randomized study. Eur Urol. 1990;17:223-225.
124. Maqsood M. Role of the thyroid in sexual development in the male. Nature. 1950;166:692.
125. Maqsood M. Thyroxine therapy in male infertility. Nature. 1951;168: 466-467.
126. Margalioth EJ, Laufer N, Persistz E, Gaulayev B, Shemesh A, Schenker JG. Treatment of oligoasthenospermia with human chorionic gonadotropin: hormonal profiles and results. Fertil Steril. 1983;39:841-844.
127. Matorras R, Perez C, Corcostegui B, Pijoan JI, Ramon O, Delgado P, Rodriguez-Escudero FJ. Treatment of the male with follicle stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum Reprod. 1997;12:24-28.
128. Matsumoto AM. Hormonal control of human spermatogenesis. In: Burger H, de Kretser D, eds. The Testis. New York. NY: Raven Press; 1989:181-196.
129. Mazumdar S, Levine AS. Antispemn antibodies: etiology, pathogenesis, diagnosis, and treatment. Fertil Steril. 1998;70:799-810.
130. Meeker JD, Godfrey-Bailey L, Hauser R. Relationships between serum hormone levels and semen quality among men from an infertility clinic. J Androl. 2007;28:397-406.
131. Meistrich ML, Wilson G, Huhtaniemi I. Hormonal therapy after cytotoxic therapy stimulates recovery of spermatogenesis. Cancer Res. 1999;59:3557-3560.
132. Miah AG, Tareq KM, Hamano K, Kohsaka T, Tsujii H. Effect of relaxin on acrosome reaction and utilization of glucose in boar spermatozoa. J Reprod Dev. 2006;52:773-779.
133. Micic S, Dotlic R. Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men. J Urol. 1985;133:221-222.
134. Mortimer CH, McNeilly AS, Fisher RA, Murray MA, Besser GM. Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunction. Br Med J. 1974;4: 617-621.
135. Moudgal NR, Murthy GS, Prasanna Kumar KM, Martin F, Suresh R, Medhamurthy R, Patil S, Sehgal S, Saxena BN. Responsiveness of human male volunteers to immunization with ovine follicle stimulating hormone vaccine: results of a pilot study. Hum Reprod. 1997;12:457-463.
136. Moudgal NR, Sairam MR. Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates? Hum Reprod. 1998;13:916-919.
137. Neuwinger J, Jockenhövel F, Nieschlag E. The influence of relaxin on motility of human sperm in vitro. Andrologia. 1990;22:335-339.
138. Newton R, Schinfeld JS, Schiff I. Clomiphene treatment of infertile men: failure of response with idiopathic oligospermia. Fertil Steril. 1980;34:399-400.
139. Nilsson S, Hellberg D. Recovery of spermatozoa after rFSH/hCG treatment, and subsequent ICSI/IVF, in a male with testicular atrophy due to severe congenital hypogonadotrophic hypogonadism. Arch Androl. 2006;52:135-138.
140. Noci I, Chelo E, Saltarelii O, Donati CG, Scarselli G. Tamoxifen and oligospermia. Arch Androl. 1985;15:83-88.
141. O'Donnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and spermatogenesis. Endocr Rev. 2001;22:289-318.
142. Okada Y, Kondo T, Okamoto S, Ogawa M. Induction of ovulation and spermatogenesis by hMG/hCG in hypogonadotropic GH deficient patients. Endocrinol Jpn. 1992;39:31-43.
143. Ovesen PG, Jørgensen JO, Ingerslev J, Orskov H, Christiansen JS. Growth hormone treatment of men with reduced sperm quality. Ugeskr Laeger. 1998;160:176-180.
144. Palti Z. Clomiphene therapy in defective spermatogenesis. Fertil Steril. 1970;21:838-843.
145. Paradisi R, Busacchi P, Seracchioli R, Porcu E, Venturoli S. Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study. Fertil Steril. 2006;86:728-731.
146. Park JM, Ewing K, Miller F, Friedman CI, Kim MH. Effects of relaxin on the fertilization capacity of human spermatozoa. Am J Obstet Gynecol. 1988;158:974-979.
147. Parker LN, Gray DY, Lai MK, Levin ER. Treatment of gynaecomastia with tamoxifen, a double-blind crossover study. Metabolism. 1986;35:705-708.
148. Patankar SS, Kaore SB, Sawane MV, Mishra NV, Deshkar AM. Effect of clomiphene citrate on sperm density in male partners of infertile couples. Indian J Physiol Pharmacol. 2007;51:195-198.
149. Paulson DF, Hammond CB, de Vere White R, Wiebe RH. Clomiphene citrate: pharmacologic treatment of hypofertile male. Urology. 1977;9:419-421.
150. Pelletier G, El-Alfy M. Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J Clin Endocrinol Metab. 2000;85:4835-4840.
151. Pelletier G, Labrie C, Labrie F. Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs. J Endocrinol. 2000;165:359-370.
152. Philip M, Arbelle JE, Segev Y, Parvari R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. New Engl J Med. 1998;338:1729-1732.
153. Plant TM, Marshall GR. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr Rev. 2001;22:764-786.
154. Pusch HH. Oral treatment of oligozoospermia with testosterone undecanoate: results of a double-blind-placebo-controlled trial. Andrologia. 1989;21:76-82.
155. Pusch HH, Pürstner P, Haas J. Treatment of asthenozoospermia with HCG. Andrologia. 1986;18:201-207.
156. Radicioni A, Paris E, Dondero F, Bonifacio V, Isidori A. Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia. Acta Eur Fertil. 1994;25:311-317.
157. Rajender S, Singh L, Thangaraj K. Phenotypic heterogeneity of mutations in androgen receptor gene. Asian J Androl. 2007;9: 147-179.
158. Rǒnnberg L. The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double-blind cross-over study. Int J Androl. 1980a;3: 479-486.
159. Rǒnnberg L. The effect of clomiphene treatment on different sperm parameters in men with idiopathic oligozoospermia. Andrologia. 1980b;12:261-265.
160. Ross LS, Kandel GL, Prinz LM, Auletta F. Clomiphene treatment of the idiopathic hypofertile male: high-dose, alternate-day therapy. Fertil Steril. 1980;33:618-623.
161. Saal W, Happ J, Cordes U, Baum RP, Schmidt M. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism. Fertil Steril. 1991;56:319-324.
162. Salvati G, Genovesi G, Marcellini L, Paolini P, De Nuccio I, Pepe M, Re M. Effects of Panax Ginseng C.A. Meyer saponins on male fertility. Panminerva Med. 1996;38:249-254.
163. Schellen TM, Beek JJ. The use of clomiphene treatment for male sterility. Fertil Steril. 1974;25:407-410.
164. Schellen TM, Beek JM. The influence of high doses of mesterolone on the spermiogram. Fertil Steril. 1972;23:712-714.
165. Schill WB, Landthaler M. Tamoxifen treatment of oligozoospermia. Andrologia. 1980;12:546-548.
166. Schill WB, Schillinger R. Selection of oligozoospermic men for tamoxifen treatment by an antiestrogen test. Andrologia. 1987;19: 266-272.
167. Schopohl J. Pulsatile gonadotropin releasing hormone versus gonadotropin treatment of hypothalamic hypogonadism in males. Hum Reprod. 1993;8:175-179.
168. Schopohl J, Mehltretter G, von Zumbusch R, Eversmann T, von Werder K. Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil Steril. 1991;56:1143-1150.
169. Schwarzstein L, Aparicio NJ, Turner D, Calamera JC, Mancini R, Schally AV. Use of synthetic luteinizing hormone-releasing hormone in treatment of oligospermic men: a preliminary report. Fertil Steril. 1975;26:331-336.
170. Sharpe RM. Follicle-stimulating hormone and spermatogenesis in the adult male. J. Endocrinol. 1989;57:152-159.
171. Shetty G, Wilson G, Huhtaniemi I, Shuttlesworth GA, Reissmann T, Meistrich ML. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats. Endocrinology. 2000;141:1735-1745.
172. Shimonovitz S, Zacut D, Benchetrit A, Ron M. Growth hormone status in patients with maturation arrest of spermatogenesis. Hum Reprod. 1993;8:919-921.
173. Shoham Z, Conway GS, Ostergaard H, Lahlou N, Bouchard P, Jacobs HS. Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism. Fertil Steril. 1992;57:1044-1051.
174. Sieber A. Endocrine fertility disorders in the male. Ther Umsch. 1992; 49:181-185.
175. Siow Y, Fallat ME, Amin FA, Belker AM. Müllerian inhibiting substance improves longevity of motility and viability of fresh and cryopreserved sperm. J Androl. 1998;19:568-572.
176. Skandhan KP, Skandhan S, Mehta YB. Semen electrolytes in normal and infertile subjects. II. Zinc. Experientia. 1978;34:1476-1477.
177. Sokol RZ, Steiner BS, Bustillo M, Petersen G, Swerdloff RS. A controlled comparison of the efficacy of clomiphene citrate in male infertility. Fertil Steril. 1988;49:865-870.
178. Spiteri-Grech J, Nieschlag E. The role of growth hormone and insulin-like growth factor I in the regulation of male reproductive function. Horm Res. 1992;38(suppl 1):22-27.
179. Sterzik K, Rosenbusch B, Grab D, Heyden M, Lichtenberger K, Wolf A. The treatment of oligozoospermia with tamoxifen does not improve sperm quality. Zentralbl Gynakol. 1991;113:683-688.
180. Sterzik K, Rosenbusch B, Mogck J, Heyden M, Lichtenberger K. Tamoxifen treatment of oligozoosperima: a re-evaluation of its effects including additional sperm function tests. Arch Gynecol Obstet. 1993;252:143-147.
181. Tachiki H, Ito N, Maruta H, Kumamoto Y, Tsukamoto T. Testicular findings, endocrine features and therapeutic responses of men with acquired hypogonadotropic hypogonadism. Int J Urol. 1998;5:80-85.
182. Tapanainen JS, Aittomaki K, Miu J, Vaskivuo T, Huttaniemi IT. Men homozygous for an inactivating mutation of the follicle stimulating hormone (FSH) receptor gene present variable suppression of
183. Török L. Treatment of oligozoospermia with tamoxifen (open and controlled studies). Andrologia. 1985;17:497-501.
184. Traub AI, Thompson W. The effect of tamoxifen on spermatogenesis in subfertile men. Andrologia. 1981;13:486-490.
185. Vermeulen A, Comhaire F. Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermic men. Fertil Steril. 1978;29:320-327.
186. Vicari E, Mongioi A, Calogero AE, Moncada ML, Sidoti G, Polosa P, D'Agata R. Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism - long-term follow-up. Int J Androl. 1992;15:320-329.
187. Vogt PH. Molecular genetics of human male infertility: from genes to new therapeutic perspectives. Curr Pharm Res. 2004;10(5):471-500.
188. Wang C, Chan CW, Wong KK, Yeung KK. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril. 1983;40:358-365.
189. Wang C, Tso SC, Todd D. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. J Clin Endocrinol Metab. 1989;68: 511-516.
190. World Health Organization Task Force on the Diagnosis and, Treatment of Infertility. Mesterolone and idiopathic male infertility: a double-blind study. Int J Androl. 1989;12:254-264.
191. Zárate A, Valdés-Vallina F,. González A, Pérez-Ubierna C, Canales ES, Schally AV. Therapeutic effect of synthetic luteinizing hormone-releasing normone (LH-RH) in male infertility due to idiopathic azoospermia and oligospermia. Fertil Steril. 1973;24: 485-486.
192. Zitzmann M, Nordhoff V, von Schönfeld V, Nordsiek-Mengede A, Kliesch S, Schüring AN, Luetjens CM, Kamischke A, Cooper T, Simoni M, Nieschlag E. Elevated follicle-stimulating hormone levels and the chances for azoospermic men to become fathers after retrieval of elongated spermatids from cryopreserved testicular tissue. Fertil Steril. 2006;86:339-347.